Document is current
Any future updates will be listed below
-
Authors
Lehrke, Michael
- License Information
-
More Information
Article History
Accepted: 17 October 2023
First Online: 4 December 2023
Interessenkonflikt
: M. Lehrke erhielt Forschungsunterstützung von Boehringer Ingelheim, MSD, Novo Nordisk und Vortragshonorare von Amgen, Sanofi, Astra Zeneca, Bayer, Lilly, Daiichi Sankyo, Novartis, Boehringer Ingelheim, MSD, Novo Nordisk.
Free to read: This content has been made available to all.
